LANADELUMAB vs LAPATINIB DITOSYLATE: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
LANADELUMAB vs LAPATINIB DITOSYLATE: Safety Overview
| Metric | LANADELUMAB | LAPATINIB DITOSYLATE |
|---|---|---|
| Total FAERS Reports | 2,058 | 3,948 |
| Deaths Reported | 109 | 921 |
| Death Rate | 5.3% | 23.3% |
| Hospitalizations | 1,007 | 752 |
| Average Patient Age | 47.3 yrs | 57.3 yrs |
| % Female Patients | 75.7% | 95.0% |
| FDA Approval Date | N/A | Aug 16, 2024 |
| Manufacturer | Takeda Pharmaceuticals America, Inc. | AvKARE |
| Route | SUBCUTANEOUS | ORAL |
| Marketing Status | N/A | Prescription |